
Tannaz armaghany MD
@tarmaghany
GI Medical Oncology, Chair,Adult Liver Cancer working group, Dan L Duncan Comprehensive Cancer Center. Baylor College of Medicine. opinions are my own.
ID: 24385695
http://www.bcm.edu 14-03-2009 15:51:01
61 Tweet
216 Followers
168 Following

My new book Hopkins Press PREVENTING THE NEXT PANDEMIC: VACCINE DIPLOMACY IN A TIME OF ANTI-SCIENCE reports on the rise in anti-science + other 21st century forces promoting emergence of #COVID19 and other diseases. Also my time as US Science Envoy Department of State amazon.com/Preventing-Nex…


A timely collaborative paper on cHCC-CCA Genomic Profiling of Combined #HepatocellularCholangiocarcinoma Reveals Genomics Similar to Either #Hepatocellular Carcinoma or #Cholangiocarcinoma ascopubs.org/doi/full/10.12… Milind Javle

From the The Nobel Prize winner Dr. Esther Duflo. Co-prize winner Dr. Banerjee is a co-author as well 👉 Effects of a large-scale social media advertising campaign on holiday travel and COVID-19 infections:a cluster randomized controlled trial @naturemedicine nature.com/articles/s4159…




Good news this morning that FDA gave full approval to the Pfizer vaccine. Glad they were able to do this now. Hope it helps get more people vaccinated as quickly as possible. BCMHouston Texas Medical Center



Upcoming webinar! Join us this 27 September for our free webinar "Systemic therapy of #CCA. Patho-molecular profile meets treatment choices". Register here: members.ilca-online.org/events/EventDe… Lorenza Rimassa #AndrewZhu Paradis valerie #MaeveLowery #LipikaGoyal


#FacultySpotlight: The following colleagues were appointed as 2025 At-Large Term Senators: Nicola A. Hanania associate professor, BCM PCCSM section; Dr. Katherine Erdman, assistant professor, Center for Medical Ethics and Health Policy; Dr. Tannaz Armaghany, assistant professor, BCM Hematology-Oncology Fellowship



Incoming NANETS president Pamela Kunz, MD, FASCO providing an excellent year in review. Highlights 🔥included research by Julie Hallet J. Bart Rose Jaydira Del Rivero, MD Heloisa Soares MD Taymeyah Al-Toubah and many more! 🦓🦓🦓



10% risk of treatment-related myeloid neoplasia (t-MN - AML or MDS) after sequential therapy with CAPTEM and PRRT. Small study but concerning numbers. Taymeyah Al-Toubah is crushing it at #NANETS2022 with 2 oral presentations in the same session. Super impressive!!





